title: Fondaparinux is an effective alternative anticoagulant in pregnant women with high risk of venous thromboembolism and intolerance to low-molecular-weight heparins and heparinoids.
authors.forename: Andrea
authors.initials: A
authors.lastname: Gerhardt
authors.forename: Rainer Bernd
authors.initials: RB
authors.lastname: Zotz
authors.forename: Marcus
authors.initials: M
authors.lastname: Stockschlaeder
authors.forename: Rüdiger Eberhard
authors.initials: RE
authors.lastname: Scharf
mesh_terms: D000328:Adult; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D004342:Drug Hypersensitivity / Q000209:etiology; D005260:Female; D000077425:Fondaparinux; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects; D006496:Heparinoids / Q000009:adverse effects; D006801:Humans; D011134:Polysaccharides / Q000627:therapeutic use*; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000517:prevention & control*; D012307:Risk Factors; D013923:Thromboembolism / Q000517:prevention & control*; D020246:Venous Thrombosis / Q000517:prevention & control*
chemical_list: D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D006496:Heparinoids; D011134:Polysaccharides; D000077425:Fondaparinux